Case number
|
ploidy
|
Age
|
INSS stage
|
MYCN amplification
|
Disease Status
|
Survival Status
|
microarray analysis
|
validation analysis
|
---|
| |
<12m=0; >12m=1
|
1,2,3,4s=0; 4=1
| | | | | |
1
|
near-3n
|
1
|
0
|
NA
|
NP
|
A
|
Y
|
Y
|
2
|
near-3n
|
1
|
0
|
NA
|
NP
|
A
|
Y
|
.
|
3
|
near-3n
|
1
|
0
|
NA
|
NP
|
A
|
Y
|
Y
|
4
|
near-3n
|
0
|
0
|
NA
|
NP
|
A
|
Y
|
.
|
5
|
near-3n
|
0
|
0
|
NA
|
NP
|
A
|
Y
|
Y
|
6
|
near-3n
|
0
|
0
|
NA
|
NP
|
A
|
Y
|
.
|
7
|
near-3n
|
0
|
0
|
NA
|
P
|
A
|
Y
|
.
|
8
|
near-3n
|
0
|
0
|
NA
|
P
|
A
|
Y
|
.
|
9
|
near-3n
|
0
|
0
|
NA
|
NP
|
A
|
Y
|
.
|
10
|
near-3n
|
0
|
0
|
NA
|
NP
|
A
|
Y
|
.
|
11
|
near-3n
|
1
|
0
|
NA
|
NP
|
A
|
Y
|
Y
|
12
|
near-3n
|
0
|
0
|
NA
|
NP
|
A
|
Y
|
.
|
13
|
near-3n
|
1
|
1
|
NA
|
P
|
D
|
Y
|
.
|
14
|
near-3n
|
1
|
0
|
NA
|
NP
|
A
|
Y
|
.
|
15
|
near-3n
|
0
|
0
|
NA
|
NP
|
A
|
Y
|
Y
|
16
|
near-3n
|
0
|
0
|
NA
|
NP
|
A
|
Y
|
.
|
17
|
near-3n
|
0
|
0
|
NA
|
P
|
A
|
Y
|
Y
|
18
|
near-3n
|
1
|
1
|
NA
|
P
|
D
|
Y
|
Y
|
19
|
near-3n
|
1
|
0
|
NA
|
NP
|
A
|
Y
|
.
|
20
|
near-3n
|
1
|
0
|
NA
|
NP
|
A
|
Y
|
Y
|
21
|
near-3n
|
0
|
0
|
NA
|
P
|
A
|
Y
|
.
|
22
|
near-3n
|
1
|
0
|
NA
|
P
|
D
|
Y
|
Y
|
23
|
near-3n
|
0
|
0
|
NA
|
NP
|
A
|
.
|
Y
|
24
|
near-3n
|
0
|
0
|
NA
|
NP
|
A
|
.
|
Y
|
25
|
near-3n
|
0
|
0
|
NA
|
NP
|
A
|
.
|
Y
|
26
|
near-3n
|
0
|
0
|
NA
|
NP
|
A
|
.
|
Y
|
27
|
near-3n
|
1
|
0
|
NA
|
NP
|
A
|
.
|
Y
|
28
|
near-3n
|
1
|
0
|
NA
|
NP
|
A
|
.
|
Y
|
29
|
near-3n
|
1
|
0
|
NA
|
NP
|
A
|
.
|
Y
|
30
|
near-3n
|
1
|
0
|
NA
|
NP
|
A
|
.
|
Y
|
31
|
near-3n
|
0
|
1
|
NA
|
NP
|
A
|
.
|
Y
|
32
|
near-3n
|
0
|
0
|
NA
|
NP
|
A
|
.
|
Y
|
33
|
near-3n
|
1
|
1
|
NA
|
P
|
A
|
.
|
Y
|
34
|
near-3n
|
0
|
0
|
NA
|
NP
|
A
|
.
|
Y
|
35
|
near-3n
|
0
|
0
|
NA
|
P
|
D
|
.
|
Y
|
36
|
near-3n
|
0
|
0
|
NA
|
NP
|
A
|
.
|
Y
|
37
|
near-3n
|
0
|
0
|
NA
|
NP
|
A
|
.
|
Y
|
38
|
near-2n
|
1
|
1
|
A
|
NP
|
A
|
Y
|
Y
|
39
|
near-2n
|
1
|
1
|
A
|
P
|
D
|
Y
|
Y
|
40
|
near-2n
|
1
|
0
|
NA
|
P
|
D
|
Y
|
.
|
41
|
near-2n
|
1
|
1
|
A
|
P
|
D
|
Y
|
Y
|
42
|
near-2n
|
1
|
1
|
A
|
P
|
A
|
Y
|
Y
|
43
|
near-2n
|
1
|
1
|
NA
|
NP
|
A
|
Y
|
Y
|
44
|
near-2n
|
1
|
1
|
NA
|
P
|
D
|
Y
|
.
|
45
|
near-2n
|
1
|
1
|
A
|
P
|
D
|
Y
|
.
|
46
|
near-2n
|
1
|
1
|
NA
|
NP
|
A
|
Y
|
.
|
47
|
near-2n
|
1
|
0
|
NA
|
P
|
D
|
Y
|
.
|
48
|
near-2n
|
1
|
0
|
NA
|
P
|
D
|
Y
|
.
|
49
|
near-2n
|
0
|
1
|
A
|
NP
|
A
|
Y
|
.
|
50
|
near-2n
|
0
|
0
|
NA
|
NP
|
A
|
Y
|
Y
|
51
|
near-2n
|
0
|
0
|
NA
|
P
|
A
|
Y
|
.
|
52
|
near-2n
|
1
|
1
|
A
|
P
|
D
|
Y
|
Y
|
53
|
near-2n
|
1
|
0
|
A
|
NP
|
A
|
Y
|
Y
|
54
|
near-2n
|
1
|
0
|
NA
|
NP
|
A
|
Y
|
.
|
55
|
near-2n
|
1
|
1
|
NA
|
P
|
D
|
Y
|
Y
|
56
|
near-2n
|
0
|
0
|
NA
|
P
|
A
|
Y
|
.
|
57
|
near-2n
|
0
|
0
|
NA
|
NP
|
A
|
Y
|
.
|
58
|
near-2n
|
1
|
1
|
NA
|
P
|
D
|
Y
|
.
|
59
|
near-2n
|
1
|
1
|
NA
|
P
|
D
|
Y
|
Y
|
60
|
near-2n
|
1
|
0
|
NA
|
P
|
D
|
Y
|
.
|
61
|
near-2n
|
0
|
0
|
NA
|
NP
|
A
|
.
|
Y
|
62
|
near-2n
|
1
|
1
|
NA
|
P
|
D
|
.
|
Y
|
63
|
near-2n
|
1
|
1
|
A
|
P
|
D
|
.
|
Y
|
64
|
near-2n
|
1
|
1
|
NA
|
NP
|
A
|
.
|
Y
|
65
|
near-2n
|
1
|
1
|
NA
|
P
|
D
|
.
|
Y
|
66
|
near-2n
|
0
|
0
|
A
|
NP
|
A
|
.
|
Y
|
67
|
near-2n
|
1
|
1
|
A
|
P
|
D
|
.
|
Y
|
68
|
near-2n
|
1
|
1
|
NA
|
P
|
A
|
.
|
Y
|
69
|
near-4n
|
1
|
0
|
NA
|
NP
|
A
|
Y
|
.
|
70
|
near-4n
|
0
|
1
|
A
|
P
|
D
|
Y
|
Y
|
71
|
near-4n
|
1
|
1
|
NA
|
NP
|
A
|
Y
|
Y
|
72
|
near-4n
|
0
|
1
|
NA
|
P
|
A
|
Y
|
.
|
73
|
near-4n
|
1
|
0
|
A
|
P
|
D
|
.
|
Y
|
74
|
near-4n
|
1
|
1
|
A
|
P
|
D
|
.
|
Y
|
- MYCN amplification status: NA = not amplified, A = amplified. Disease status: NP = no disease progression, P = disease progression. Survival status: A = alive, D = dead. Microarray and validation analyses: Y = cases analyzed.